newsfilter
← Latest News
GlobeNewswire·

Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference

  • Editas Medicine will present two posters at the ESGCT 33rd Annual Congress in Hamburg, Germany, from October 27-30, 2026.
  • The first poster (P0361), presented by Harry An, covers novel targeted LNP delivery for in vivo CAR-T cell generation & B-cell depletion.
  • The second poster (P0781), also presented by Harry An, details a configurable, GMP-ready manufacturing platform for targeted LNP therapeutics.
  • Both posters will be displayed during Poster Session 1 on Wednesday, October 28, 2026, from 1:30 to 3:30 p.m. CET.
  • Management will participate in a Fireside Chat at the Guggenheim 3rd Annual Healthcare Innovation Conference on November 10, 2026, at 2:30 p.m. ET in Boston.
  • Editas Medicine is the exclusive licensee of Broad Institute's Cas12a & Cas9 patent estates for human medicines.
  • Abstracts & presentations will be available on the conference website & the company's "Posters & Presentations" section, with a webcast replay of the November event available for 30 days.